Paradox Immunotherapeutics
Toronto
About Paradox Immunotherapeutics
Paradox Immunotherapeutics is a pharmaceutical company that develops treatments for patients suffering from rare amyloid diseases. It uses an immunotherapy drug design platform to design drugs that harness the body’s own immune system to clear lethal deposits from affected organs and reverse organ damage.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $10.0M
- Last round: Series Unknown (Feb 2025)
- Website: paradoximmuno.com
Industries & Categories
Biotechnology, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/paradox-immunotherapeutics-81659 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.